These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2576866)

  • 21. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
    Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental studies on transmission of EHF in rodents].
    Zhang Y; Tao KH; Zhao XZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 May; 28(3):132-5. PubMed ID: 7842865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins.
    Xu X; Ruo SL; McCormick JB; Fisher-Hoch SP
    Am J Trop Med Hyg; 1992 Oct; 47(4):397-404. PubMed ID: 1359802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serotyping of patients with epidemic hemorrhagic fever (EHF) and serotyping and antigen typing of main hosts of EHF in Shandong province].
    Yang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):41-4. PubMed ID: 8099309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemagglutination-inhibiting antibody in hemorrhagic fever with renal syndrome.
    Tsai TF; Tang YW; Hu SL; Ye KL; Chen GL; Xu ZY
    J Infect Dis; 1984 Dec; 150(6):895-8. PubMed ID: 6150063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Approaches to selecting a strain of hantavirus for developing an inactivated brain vaccine].
    Astakhova TI; Slonova RA; Kompanets GG
    Vopr Virusol; 1997; 42(3):105-8. PubMed ID: 9297337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term immunogenicity and safety of inactivated Hantaan virus vaccine (Hantavax™) in healthy adults.
    Song JY; Woo HJ; Cheong HJ; Noh JY; Baek LJ; Kim WJ
    Vaccine; 2016 Mar; 34(10):1289-95. PubMed ID: 26826547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary trials of inactivated vaccine against haemorrhagic fever with renal syndrome.
    Song G; Hang CS; Huang YC; Hou FY
    Lancet; 1991 Mar; 337(8744):801. PubMed ID: 1672432
    [No Abstract]   [Full Text] [Related]  

  • 29. [A combined staining of immunohistochemistry and in situ hybridization for detecting epidemic hemorrhagic fever virus in tissue section].
    Tang ZJ
    Zhonghua Bing Li Xue Za Zhi; 1993 Jun; 22(3):140-2. PubMed ID: 8106176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response to rubella virus proteins in different physical forms.
    Trudel M; Nadon F; Comtois R; Ravaoarinoro M; Payment P
    Antiviral Res; 1982 Dec; 2(6):347-54. PubMed ID: 7165297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
    Wang S; Parker C; Taaffe J; Solórzano A; García-Sastre A; Lu S
    Vaccine; 2008 Jul; 26(29-30):3626-33. PubMed ID: 18538900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The distribution of epidemic hemorrhagic fever (EHF) viral antigen in tissues from EHF autopsies].
    Yi XP; Xing SF
    Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):110-2. PubMed ID: 1680572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of immunofluorescence and hemagglutination inhibition tests and enzyme-linked immunosorbent assay for detection of serum antibody in rats infected with hemorrhagic fever with renal syndrome virus.
    Takahashi Y; Okuno Y; Yamanouchi T; Takada N; Yamanishi K
    J Clin Microbiol; 1986 Nov; 24(5):712-5. PubMed ID: 2877007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The duration of viremia patients with epidemic hemorrhagic fever.
    Yao ZQ; Yang WS; Zhang WB; Bai XF
    Chin Med J (Engl); 1989 Feb; 102(2):116-9. PubMed ID: 2570679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experiment research on moxibustion treating infected EHFV rat].
    Tang Z; Song X; Liu B; Zhou M; Dong C; Ni D
    Zhen Ci Yan Jiu; 1990; 15(4):302-5. PubMed ID: 1980432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines for hantaviruses: progress and issues.
    Schmaljohn CS
    Expert Rev Vaccines; 2012 May; 11(5):511-3. PubMed ID: 22827236
    [No Abstract]   [Full Text] [Related]  

  • 37. [Transmission of epidemic hemorrhagic fever virus between mice and mites in EHF endemic areas].
    Zhang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 1987 Nov; 21(6):325-7. PubMed ID: 2898326
    [No Abstract]   [Full Text] [Related]  

  • 38. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.
    Pereira RC; Silva AN; Souza MC; Silva MV; Neves PP; Silva AA; Matos DD; Herrera MA; Yamamura AM; Freire MS; Gaspar LP; Caride E
    Vaccine; 2015 Aug; 33(35):4261-8. PubMed ID: 25862300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines.
    Norrby E; Penttinen K
    J Infect Dis; 1978 Nov; 138(5):672-6. PubMed ID: 712121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
    Rota PA; De BK; Shaw MW; Black RA; Gamble WC; Kendal AP
    Virus Res; 1990 Apr; 16(1):83-93. PubMed ID: 2349834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.